Shiyou X. Wei
No.17, The 3rd Section Of The South Of Renmin Road
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Author Correction: A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities.
Journal: Nature communications
Published: April 15, 2026
Editorial: Treatment response and resistance to targeted therapies for NSCLC.
Journal: Frontiers in oncology
Published: January 03, 2026
A telomerase-SUCLG2 signaling axis drives drug resistance by protecting persister cells.
Journal: Cell reports
Published: October 11, 2025
PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial.
Journal: Nature communications
Published: September 13, 2025
A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities.
Journal: Nature communications
Published: September 10, 2025
Effect of Surgical Resection on Isolated Pleural Dissemination in Patients with Stage IV (M1a) Non-Small Cell Lung Cancer: Analysis from a Cohort-Based Registry and a Population-Based Database.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: August 20, 2025
Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of ROS1 + or ALK + non-small cell lung cancer to crizotinib therapy.
Journal: Translational lung cancer research
Published: February 23, 2025
A retrospective study on unfavorable 28-day neurological outcomes of stage II TB meningitis.
Journal: Scientific reports
Published: November 10, 2024
Using human genetics to understand the epidemiological association between neuroticism and lung cancer.
Journal: Translational lung cancer research
Published: October 15, 2024
A Comprehensive Proteogenomic and Spatial Analysis of Innate and Acquired Resistance of Metastatic Melanoma to Immune Checkpoint Blockade Therapies.
Journal: bioRxiv : the preprint server for biology
Published: September 24, 2024
Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target.
Journal: Genome medicine
Published: September 17, 2024
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trial.
Journal: Med (New York, N.Y.)
Published: August 14, 2024
Last Updated: 09/26/2026